RESUMEN
In forensic toxicology, a marker of street heroin use is urgent especially in the absence of urinary 6-monoacetylmorphine. ATM4G, the Glucuronide of Acetylated product of Thebaine compound 4 Metabolite (ATM4), arising from byproducts of street heroin synthesis has been considered as a useful marker in some European studies. However, whether ATM4G is a universal marker particularly in Southeast Asia due to 'street' heroin with high purity, it's still unclear. To investigate putative markers for different regions, ATM4G and other metabolites including the Acetylated product of Thebaine compound 3 Metabolite (ATM3) and thebaol, also originated from thebaine were detected in 552 urine samples from heroin users in Taiwan. Results were compared with that from samples collected in the UK and Germany. Only a sulfo-conjugate of ATM4, ATM4S, was detected in 28 Taiwanese users using a sensitive MS3 method whilst out of 351 samples from the UK and Germany, ATM4G was present in 91. Thebaol-glucuronide was first time detected in 118. No markers were detected in urine following herbal medicine use or poppy seed ingestion. The presence of ATM4S/ATM4G might be affected by ethnicities and heroin supplied in regions. Thebaol-glucuronide is another putative marker with ATM4G and ATM4S for street heroin use.
Asunto(s)
Toxicología Forense/métodos , Glucurónidos/orina , Heroína/metabolismo , Detección de Abuso de Sustancias/métodos , Asia Sudoriental , Europa (Continente) , Cromatografía de Gases y Espectrometría de Masas/métodos , Heroína/orina , Humanos , Derivados de la Morfina/orina , Tebaína/orinaRESUMEN
Here, we use optogenetics and chemogenetics to investigate the contribution of the paraventricular thalamus (PVT) to nucleus accumbens (NAc) pathway in aversion and heroin relapse in two different heroin self-administration models in rats. In one model, rats undergo forced abstinence in the home cage prior to relapse testing, and in the other, they undergo extinction training, a procedure that is likened to cognitive behavioral therapy. We find that the PVTâNAc pathway is both sufficient and necessary to drive aversion and heroin seeking after abstinence, but not extinction. The ability of extinction to reduce this pathway's contribution to heroin relapse is accompanied by a loss of synaptic plasticity in PVT inputs onto a specific subset of NAc neurons. Thus, extinction may exert therapeutic reductions in opioid seeking by altering synaptic plasticity within the PVTâNAc pathway, resulting in reduced aversion during opioid withdrawal as well as reduced relapse propensity.
Asunto(s)
Extinción Psicológica/fisiología , Heroína/metabolismo , Plasticidad Neuronal/fisiología , Tálamo/fisiología , Animales , Ratones , Neuronas/metabolismo , Núcleo Accumbens/fisiología , Ratas , Recurrencia , Autoadministración/métodosRESUMEN
Confirmation or exclusion of recent heroin consumption is still one of the major challenges for forensic and clinical toxicologists. A great variety of biomarkers is available for heroin abuse confirmation, including various opium alkaloids (eg, morphine, codeine), street heroin impurities (eg, 6-acetylcodeine [6-AC], noscapine, papaverine) as well as associated metabolites (eg, 6-monoacetylmorphine [6-MAM], morphine glucuronides). However, the presence of most of these biomarkers cannot solely be attributed to a previous heroin administration but can, among other things, also be due to consumption of poppy seed products ('poppy seed defense'), opium preparations or specific medications, respectively. A reliable allocation is of great importance in different contexts, for instance in the case of DUID (driving under the influence of drugs) investigations, in driving licence re-granting processes, in workplace drug testing (WDT), as well as in post-mortem identification of illicit opiate use. Additionally, differentiation between illicit street heroin abuse and pharmaceutical heroin administration is also important, especially within the frame of heroin-assisted treatments. Therefore, analysis of multiple biomarkers is recommended when illicit opiate consumption is assumed to obtain the most reliable results possible. Beyond that, interpretation of positive opiate test results requires a profound insight into the great variety of biomarkers available and their validity regarding the alleged consumption. This paper aims to provide an overview of the wide variety of heroin abuse biomarkers described in the literature and to review them regarding their utility and reliability in daily routine analysis.
Asunto(s)
Dependencia de Heroína/diagnóstico , Dependencia de Heroína/metabolismo , Heroína/metabolismo , Detección de Abuso de Sustancias/normas , Biomarcadores/análisis , Codeína/análogos & derivados , Codeína/análisis , Codeína/metabolismo , Glucurónidos/análisis , Glucurónidos/metabolismo , Heroína/análisis , Humanos , Derivados de la Morfina/análisis , Derivados de la Morfina/metabolismo , Opio/análisis , Opio/metabolismo , Reproducibilidad de los Resultados , Detección de Abuso de Sustancias/métodosAsunto(s)
Biotecnología/métodos , Tráfico de Drogas/prevención & control , Heroína/metabolismo , Ingeniería Metabólica , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Animales , Bencilisoquinolinas/metabolismo , Beta vulgaris/enzimología , Beta vulgaris/genética , Humanos , Morfina/biosíntesis , Biología SintéticaRESUMEN
The therapeutic effects of melatonin or vitamin E plus Se (vE + Se) on the restrain of the heroin withdrawal-induced oxidative stress were studied. For this, rats were divided into ten groups. The rats were injected by fixed or variable doses of heroin for 16 consecutive days, and naloxone was given 1 h after the last heroin injection. One hour after naloxone administration, some groups were treated with melatonin or vE + Se. After 1 h this, blood samples were taken, and the levels of malondialdehyde (MDA) and reduced glutathione (GSH) in whole blood, ascorbic acid, α-tocopherol, retinol, ß-carotene, nitrite, nitrate, and ceruloplasmin levels in the serum were measured. Our findings showed that, naloxone administration precipitated the heroin withdrawal. This also increased the level of MDA and decreased the levels of GSH in blood. Melatonin or vE + Se administration prevented the rise in MDA levels and increased the GSH levels. On the other hand, there were some significant differences between α-tocopherol, retinol, ß-carotene, nitrite, nitrate, and ceruloplasmin levels of experimental groups. Results of present study showed that heroin withdrawal increased the lipid peroxidation and depressed endogenous antioxidative systems. Additionally, melatonin or vE + Se administrations prevented lipid peroxidation and augmented endogenous antioxidant defense systems.
Asunto(s)
Dependencia de Heroína/tratamiento farmacológico , Melatonina/uso terapéutico , Naloxona/farmacología , Estrés Oxidativo , Selenio/uso terapéutico , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Vitamina E/uso terapéutico , Animales , Antioxidantes/uso terapéutico , Ceruloplasmina/análisis , Glutatión/sangre , Heroína/metabolismo , Peroxidación de Lípido , Masculino , Malondialdehído/sangre , Nitratos/sangre , Nitritos/sangre , Ratas , Ratas Sprague-DawleyRESUMEN
There are a few studies with conflicting results on the effects of opioids on the functioning of immune system. This study was performed to investigate the in vitro production of interferon-gamma and interleukin-10 after antigenic stimulation of cells using whole blood from opioid addicts. Blood samples were taken from 20 chronically opioid-addicted persons, who voluntarily enrolled for detoxification (10 opium and 10 heroin addicts). Blood samples were also taken from 10 healthy individuals with no history of drug abuse as the control. Cell culture was performed in a whole blood culture assay. Diluted blood samples were stimulated with phytohemagglutinin or with lipopolysaccharide and the supernatants were collected to measure cytokine production. The results demonstrated a significant decrease in interferon-gamma production and an increase in interleukin-10 secretion in heroin addicts, relative to the control group (35.9+/-26.3 versus 110.2+/-60.3 pg/mL, p<0.01 and 71.8+/-28.4 versus 17.1+/-13.5 pg/mL, p<0.01, respectively), however the changes in these values in opium addicts were not significant compared to healthy individuals. The results could suggest that opioid addiction leads to a shift in the Th1/Th2 cytokine balance of peripheral CD4+ cells towards the Th2 response, and opioid addicts demonstrate reduced mitogenic responsiveness of lymphocytes relative to healthy individuals.
Asunto(s)
Analgésicos Opioides/metabolismo , Citocinas/metabolismo , Células TH1/metabolismo , Células Th2/metabolismo , Adulto , Antígenos/metabolismo , Linfocitos T CD4-Positivos/metabolismo , Hemaglutininas/química , Heroína/metabolismo , Humanos , Interleucina-10/metabolismo , Lipopolisacáridos/metabolismo , Mitógenos/metabolismo , Opio/metabolismo , Trastornos Relacionados con SustanciasRESUMEN
Using c-Fos protein immunohistochemistry we previously demonstrated various sites of activation in the rat forebrain according to the animal's drug history. This study originates from a more detailed evaluation ex-post of the same specimens. A discrete number of c-Fos protein immunoreactive nuclei could be observed in some circumventricular organs, including the vascular organ of terminal lamina (OVLT) and subfornical organ (SFO) and in the nucleus of solitary tract near the area postrema, but only in specimens from sensitized rats. We therefore suggest that repeated drug injections activate the normally low drug metabolizing enzyme activity in the circumventricular organs thus implicating these organs in the complex mechanisms underlying behavioral sensitization.
Asunto(s)
Heroína/farmacología , Hipotálamo/efectos de los fármacos , Núcleo Solitario/efectos de los fármacos , Órgano Subfornical/efectos de los fármacos , Animales , Área Postrema/efectos de los fármacos , Área Postrema/metabolismo , Modelos Animales de Enfermedad , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Enzimas/efectos de los fármacos , Enzimas/metabolismo , Heroína/metabolismo , Dependencia de Heroína/metabolismo , Dependencia de Heroína/fisiopatología , Hipotálamo/metabolismo , Inmunohistoquímica , Narcóticos/metabolismo , Narcóticos/farmacología , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/metabolismo , Proteínas Proto-Oncogénicas c-fos/efectos de los fármacos , Proteínas Proto-Oncogénicas c-fos/metabolismo , Ratas , Ratas Sprague-Dawley , Núcleo Solitario/metabolismo , Órgano Subfornical/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/fisiologíaAsunto(s)
Ácidos Araquidónicos , Encéfalo/fisiología , Cannabinoides/metabolismo , Heroína/metabolismo , Receptores Opioides/metabolismo , Amidas/química , Animales , Cannabinoides/farmacología , Dronabinol/química , Dronabinol/metabolismo , Dronabinol/farmacología , Endocannabinoides , Encefalina Leucina/química , Ácidos Grasos Insaturados/química , Heroína/farmacología , Humanos , Morfina/química , Alcamidas Poliinsaturadas , Receptores Opioides/efectos de los fármacos , Relación Estructura-Actividad , TéRESUMEN
We report a sensitive, rapid, quantitative gas chromatographic/mass spectroscopic method for measuring the 6-monoacetylmorphine (6-MAM) metabolite of heroin in 0.5 mL of human urine. After a simple liquid-liquid extraction and derivatization, the trimethylsilyl derivative of 6-MAM is identified from its retention time (total ion current) and by selected ion monitoring. The limit of detection was 10 micrograms/L, corresponding to 0.2 ng of trimethylsilyl-6-MAM injected into the gas chromatograph/mass spectrometer. The presence of 6-MAM in urine is indicative of heroin. 6-MAM is not present in poppy seeds or in urine after the ingestion of products containing poppy seed.
Asunto(s)
Heroína , Derivados de la Morfina/orina , Papaver , Plantas Medicinales , Semillas/análisis , Trastornos Relacionados con Sustancias/orina , Reacciones Falso Positivas , Cromatografía de Gases y Espectrometría de Masas/métodos , Heroína/metabolismo , Humanos , Morfina/metabolismo , Compuestos de TrimetilsililoRESUMEN
Heroin is currently being advocated by some as a superior therapeutic agent for use in terminal illness. However, a review of the literature on heroin presently available does not support this contention. Administered orally, heroin is approximately 1.5 times more potent than morphine in controlling chronic pain in terminal cancer patients. Its effects on mood and the incidence and nature of side effects do not differ from those of morphine except in males where poorer pain control probably accounts for the worse effect on mood. Given parenterally for acute pain, heroin is 2-4 times more potent than morphine and faster in onset of action. When the potency difference is accounted for, the pharmacological effects of heroin do not differ appreciably from those of morphine. Heroin is metabolized to 6-acetylmorphine and morphine. After oral administration of heroin, morphine but not heroin or 6-acetylmorphine is detected in blood. In this case, heroin is a prodrug for the delivery of systemic morphine. Following acute i.v. administration, heroin appears transiently in blood with a half-life of about 3 min. The half-life of heroin exposed to blood or serum in vitro is 9-22 min, indicating that organ metabolism is involved in blood clearance as well. Direct renal clearance of heroin is less than 1% of the administered dose. In animal studies, heroin and 6-acetylmorphine are both more potent and faster acting than morphine as analgesics, effects attributed to their greater lipid solubility and subsequent penetration of the blood-brain barrier. Given centrally, morphine is more potent than heroin and 6-acetylmorphine in producing analgesia.(ABSTRACT TRUNCATED AT 250 WORDS)